Skip to main content
. Author manuscript; available in PMC: 2018 Jun 1.
Published in final edited form as: Mol Cancer Ther. 2017 Mar 6;16(6):1114–1123. doi: 10.1158/1535-7163.MCT-16-0541

Figure 2. In situ hybridization for anti-EphA2 siRNA in mouse spleen and brain.

Figure 2

(A) Spleen, EPHARNA treated mouse, control probe; (B) Spleen, EPHARNA treated mouse, anti-siRNA probe; (C) CNS, EPHARNA treated mouse, control probe; (D) CNS, EPHARNA treated mouse, anti-siRNA probe; (E) Spleen, Control DOPC treated mouse, control probe (F) Spleen, control DOPC treated mouse, anti-siRNA probe; (G) CNS, control DOPC treated mouse, control probe; (H) CNS, control DOPC treated mouse, anti-siRNA probe